Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Walgreens Boots Alliance To Reduce Stake In China Pharmaceutical Wholesaler

By Walgreens Boots Alliance, Inc. | December 26, 2017

Walgreens Boots Alliance, Inc. has entered into an agreement to reduce its stake in Guangzhou Pharmaceuticals Corporation, a pharmaceutical wholesaling joint venture in China, following an offer from its joint venture partner Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.

Subject to regulatory review and approval and other customary closing conditions, Walgreens Boots Alliance will sell a 30 percent interest in Guangzhou Pharmaceuticals Corporation to Guangzhou Baiyunshan Pharmaceutical Holdings that, following the proposed sale, would own 80 percent.

Upon completion, Walgreens Boots Alliance will own a 20 percent interest in Guangzhou Pharmaceuticals Corporation and will continue to account for its remaining stake as an equity method investment.

Walgreens Boots Alliance and the companies in which it has equity method investments together have a presence in more than 25* countries, employ more than 385,000* people, and have more than 13,200* stores in 11* countries. It has more than 390* distribution centers delivering to more than 230,000** pharmacies, doctors, health centers, and hospitals in more than 20* countries.

In addition, it is one of the world’s largest purchasers of prescription drugs and other health and wellbeing products.

* As of August, 31, 2017, using publicly available information for AmerisourceBergen.
** For 12 months ending August, 31, 2017 using publicly available information for AmerisourceBergen.

(Source: Walgreens Boots Alliance, Inc.)

Related Articles Read More >

Building a resilient pharma supply chain
Antheia_Logo (1)
Pharma ingredient manufacturer Antheia raises $56M Series C
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE